Financials Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
115.6 USD +2.49% Intraday chart for Illumina, Inc. +2.45% -16.99%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 48,766 54,020 59,465 31,806 22,111 18,407 - -
Enterprise Value (EV) 1 46,493 51,732 59,821 32,504 22,546 18,535 17,754 17,219
P/E ratio 49.2 x 83.1 x 75.5 x -7.22 x -19 x -46.4 x 184 x 25.6 x
Yield - - - - - - - -
Capitalization / Revenue 13.8 x 16.7 x 13.1 x 6.94 x 4.91 x 4.07 x 3.75 x 3.43 x
EV / Revenue 13.1 x 16 x 13.2 x 7.09 x 5.01 x 4.1 x 3.61 x 3.21 x
EV / EBITDA 37.8 x 56.5 x 46.8 x 45.9 x 46.2 x 44.6 x 26.7 x 17.1 x
EV / FCF 55.2 x 58.1 x 178 x 307 x 79.7 x 9.34 x 13.1 x 16.7 x
FCF Yield 1.81% 1.72% 0.56% 0.33% 1.26% 10.7% 7.65% 6%
Price to Book 10.6 x 11.6 x 5.56 x - - 2.7 x 2.62 x 2.68 x
Nbr of stocks (in thousands) 147,000 146,000 156,305 157,300 158,800 159,255 - -
Reference price 2 331.7 370.0 380.4 202.2 139.2 115.6 115.6 115.6
Announcement Date 1/29/20 2/11/21 2/10/22 2/7/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,543 3,239 4,526 4,584 4,504 4,523 4,915 5,360
EBITDA 1 1,231 916 1,277 708 488 415.9 664.6 1,007
EBIT 1 1,076 758 1,096 487 247 230.1 532.1 701
Operating Margin 30.37% 23.4% 24.22% 10.62% 5.48% 5.09% 10.83% 13.08%
Earnings before Tax (EBT) 1 1,118 856 884 -4,336 -1,117 -413.9 266.5 474.4
Net income 1 1,002 656 762 -4,404 -1,161 -321.3 418.9 671.2
Net margin 28.28% 20.25% 16.84% -96.07% -25.78% -7.1% 8.52% 12.52%
EPS 2 6.740 4.450 5.040 -28.00 -7.340 -2.492 0.6290 4.523
Free Cash Flow 1 842 891 337 106 283 1,984 1,358 1,032
FCF margin 23.77% 27.51% 7.45% 2.31% 6.28% 43.87% 27.64% 19.26%
FCF Conversion (EBITDA) 68.4% 97.27% 26.39% 14.97% 57.99% 477.08% 204.42% 102.51%
FCF Conversion (Net income) 84.03% 135.82% 44.23% - - - 324.31% 153.82%
Dividend per Share 2 - - - - - - - -
Announcement Date 1/29/20 2/11/21 2/10/22 2/7/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,198 1,223 1,162 1,115 1,083 1,087 1,176 1,119 1,122 1,076 1,098 1,140 1,194 1,164 1,191
EBITDA 1 196 263 194 159 90 80 143 154 113 93 98.17 115.6 144.5 114.3 112.9
EBIT 1 146 212 141 102 31 21 82 93 51 33 36.18 60.71 82.37 76.25 92.86
Operating Margin 12.19% 17.33% 12.13% 9.15% 2.86% 1.93% 6.97% 8.31% 4.55% 3.07% 3.3% 5.32% 6.9% 6.55% 7.8%
Earnings before Tax (EBT) 1 86 140 -637 -3,672 -168 -78 -89 -782 -168 -109 -88.7 26.7 45 42.83 52.1
Net income 1 112 86 -535 -3,816 -140 3 -234 -754 -176 -126 -69.88 -11.33 4.25 62.8 107
Net margin 9.35% 7.03% -46.04% -342.24% -12.93% 0.28% -19.9% -67.38% -15.69% -11.71% -6.37% -0.99% 0.36% 5.4% 8.98%
EPS 2 0.7100 0.5500 -3.400 -24.26 -0.8900 0.0200 -1.480 -4.770 -1.110 -0.7900 -0.6418 -0.4338 -0.2835 0.7300 0.6800
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/10/22 5/5/22 8/11/22 11/3/22 2/7/23 4/25/23 8/9/23 11/9/23 2/8/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 356 698 435 128 - -
Net Cash position 1 2,273 2,288 - - - - 653 1,187
Leverage (Debt/EBITDA) - - 0.2788 x 0.9859 x 0.8914 x 0.3078 x - -
Free Cash Flow 1 842 891 337 106 283 1,984 1,358 1,032
ROE (net income / shareholders' equity) 23.1% 14.3% 11.6% 3.88% 2.22% 1.61% 3.77% 6.7%
ROA (Net income/ Total Assets) 13.7% 8.91% 7.82% 2.45% 1.23% 1.41% 2.99% -
Assets 1 7,328 7,361 9,739 -180,020 -94,760 -20,758 10,468 -
Book Value Per Share 2 31.40 31.90 68.40 - - 40.30 42.90 40.60
Cash Flow per Share 2 7.050 7.300 3.610 2.500 3.030 1.850 4.570 6.010
Capex 1 209 189 208 286 195 219 236 258
Capex / Sales 5.9% 5.84% 4.6% 6.24% 4.33% 4.84% 4.8% 4.82%
Announcement Date 1/29/20 2/11/21 2/10/22 2/7/23 2/8/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
115.6 USD
Average target price
156.1 USD
Spread / Average Target
+35.06%
Consensus
  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. Financials Illumina, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW